insights_auto
Why is BHC down 2.31%?
Dive Deeperchevron_right
BHC:NYSE
Bausch Health Companies Inc
$8.02
arrow_downward
-2.31%(-0.19) 1D
$8.12
arrow_upward
+1.21% (+0.097)bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
$8.21
High
$8.34
Low
$7.96
Mkt. cap
3.00B
Avg. vol.
3.35M
Volume
316.00
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.37
Shares outstanding
374.27M
No. of employees
20K
Open
$8.21
High
$8.34
Low
$7.96
Mkt. cap
3.00B
Avg. vol.
3.35M
Volume
316.00
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.37
Shares outstanding
374.27M
No. of employees
20K
News stories
From web sources and news partners
kalkine.ca
·
21 hours ago
Is Bausch Health Companies Inc. (BHC:TSX) Facing a Critical Test of Its Financial Recovery?
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3K
Founded1960
HeadquartersLaval, Quebec, Canada
SectorPharmaceutical industry
Websitebauschhealth.com